| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
E
7 (CD103) Expression Identifies a Highly Active, Tonsil-Resident Effector-Memory CTL Population1
* Partners AIDS Research Center and
Oral and Maxillofacial Surgery, Massachusetts General Hospital, Boston, MA 02129;
New England Primate Research Center, Harvard Medical School, Southborough, MA 01772;
University Hospital, Basel, Switzerland; and
¶
Department of Pathology and
||
Channing Laboratories, Brigham and Women’s Hospital, Boston, MA 02115
The characterization of antiviral CTL responses has largely been limited to assessing Ag-specific immune responses in the peripheral blood. Consequently, there is an incomplete understanding of the cellular immune responses at mucosal sites where many viruses enter and initially replicate and how the Ag specificity and activation status of CTL derived from these mucosal sites may differ from that of blood-derived CTL. In this study, we show that EBV-specific CTL responses in the tonsils are of comparable specificity and breadth but of a significantly higher magnitude compared with responses in the peripheral blood. EBV-specific, tonsil-resident, but not PBMC-derived, T cells expressed the integrin/activation marker CD103 (
E
7), consistent with the detection of its ligand, E-cadherin, on tonsillar squamous cells. These CD8-positive, CD103-positive, tonsil-derived CTL were largely CCR7- and CD45RA- negative effector-memory cells and responded to lower Ag concentrations in in vitro assays than their CD103-negative PBMC-derived counterparts. Thus, EBV-specific CTL in the tonsil, a crucial site for EBV entry and replication, are of greater magnitude and phenotypically distinct from CTL in the peripheral blood and may be important for effective control of this orally transmitted virus.
This article has been cited by other articles:
|
|
 |
|
  P. K. Suvas, H. M. Dech, F. Sambira, J. Zeng, and T. M. Onami Systemic and Mucosal Infection Program Protective Memory CD8 T Cells in the Vaginal Mucosa J. Immunol., December 15, 2007; 179(12): 8122 - 8127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Brainard, A. M. Tager, J. Misdraji, N. Frahm, M. Lichterfeld, R. Draenert, C. Brander, B. D. Walker, and A. D. Luster Decreased CXCR3+ CD8 T Cells in Advanced Human Immunodeficiency Virus Infection Suggest that a Homing Defect Contributes to Cytotoxic T-Lymphocyte Dysfunction J. Virol., August 15, 2007; 81(16): 8439 - 8450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Floc'h, A. Jalil, I. Vergnon, B. L. M. Chansac, V. Lazar, G. Bismuth, S. Chouaib, and F. Mami-Chouaib {alpha}E{beta}7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis J. Exp. Med., March 19, 2007; 204(3): 559 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Ivakine, S. M. Mortin-Toth, O. M. Gulban, A. Valova, A. Canty, C. Scott, and J. S. Danska The Idd4 Locus Displays Sex-Specific Epistatic Effects on Type 1 Diabetes Susceptibility in Nonobese Diabetic Mice Diabetes, December 1, 2006; 55(12): 3611 - 3619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Uss, A. T. Rowshani, B. Hooibrink, N. M. Lardy, R. A. W. van Lier, and I. J. M. ten Berge CD103 Is a Marker for Alloantigen-Induced Regulatory CD8+ T Cells. J. Immunol., September 1, 2006; 177(5): 2775 - 2783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bihl, N. Frahm, L. Di Giammarino, J. Sidney, M. John, K. Yusim, T. Woodberry, K. Sango, H. S. Hewitt, L. Henry, et al. Impact of HLA-B Alleles, Epitope Binding Affinity, Functional Avidity, and Viral Coinfection on the Immunodominance of Virus-Specific CTL Responses J. Immunol., April 1, 2006; 176(7): 4094 - 4101. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
